The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer

Seminars in Nuclear Medicine

Volumn 42, Issue 5, 2012, Pages 308-319

  Mac Manus, Michael P ^a   Hicks, Rodney J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MULTIMODALITY CANCER THERAPY; PATIENT SELECTION; RADIATION DOSE; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; TUMOR VOLUME;

EID: 84864411911     PISSN: 00012998     EISSN: 15584623     Source Type: Journal    
DOI: 10.1053/j.semnuclmed.2012.04.003     Document Type: Review

References (65)

1. D. De Ruysscher, U. Nestle, R. Jeraj PET scans in radiotherapy planning of lung cancer Lung Cancer 75 2012 141 145
2. M. Pijls-Johannesma, R. Houben, L. Boersma High-dose radiotherapy or concurrent chemo-radiation in lung cancer patients only induces a temporary, reversible decline in QoL Radiother Oncol 91 2009 443 448
3. V. Kalff, R.J. Hicks, M.P. MacManus Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study J Clin Oncol 19 2001 111 118
4. R. Remonnay, M. Morelle, P. Pommier Assessing short-term effects and costs at an early stage of innovation: The use of positron emission tomography on radiotherapy treatment decision making Int J Technol Assess Health Care 24 2008 212 220
5. M.P. Mac Manus, R.J. Hicks How can we tell if PET imaging for cancer is cost effective? Lancet Oncol 11 2010 711 712
6. U. Nestle, W. Weber, M. Hentschel Biological imaging in radiation therapy: Role of positron emission tomography Phys Med Biol 54 2009 R1 R25
7. K. Chansky, J.P. Sculier, J.J. Crowley The International Association for the Study of Lung Cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer J Thorac Oncol 4 2009 792 801
8. P. Goldstraw, R. Rami-Porta, J. Crowley We probably have the answer: Now what is the question? J Thorac Oncol 4 2009 939 940
9. F.M. Smolle-Juettner, A. Maier, J. Lindenmann Resection in stage I/II non-small cell lung cancer Front Radiat Ther Oncol 42 2010 71 77
10. K.S. Albain, R.S. Swann, V.W. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: A phase III randomised controlled trial Lancet 374 2009 379 386
11. M.K. Gould, C.C. Maclean, W.G. Kuschner Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis JAMA 285 2001 914 924
12. S.C. Huang Anatomy of SUV Standardized uptake value Nucl Med Biol 27 2000 643 646
13. H. Nomori, K. Watanabe, T. Ohtsuka Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size Ann Thorac Surg 79 2005 984 988 discussion 989
14. H. van Tinteren, O.S. Hoekstra, E.F. Smit Toward less futile surgery in non-small cell lung cancer? A randomized clinical trial to evaluate the cost-effectiveness of positron emission tomography Control Clin Trials 22 2001 89 98
15. R. Sogaard, B.M. Fischer, J. Mortensen Preoperative staging of lung cancer with PET/CT: Cost-effectiveness evaluation alongside a randomized controlled trial Eur J Nucl Med Mol Imaging 38 2011 802 809
16. D.E. Maziak, G.E. Darling, R.I. Inculet Positron emission tomography in staging early lung cancer: A randomized trial Ann Intern Med 151 2009 221 228 W-248
17. 18 F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: A Dutch cooperative randomized study J Clin Oncol 24 2006 1800 1806
18. M.K. Gould, W.G. Kuschner, C.E. Rydzak Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: A meta-analysis Ann Intern Med 139 2003 879 892
19. E.M. Toloza, L. Harpole, D.C. McCrory Noninvasive staging of non-small cell lung cancer: A review of the current evidence Chest 123 2003 137S 146S
20. M.P. Mac Manus, R.J. Hicks, J.P. Matthews High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: Implications for radical radiation therapy Int J Radiat Oncol Biol Phys 50 2001 287 293
21. M.P. MacManus, R.J. Hicks, D.L. Ball F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment Cancer 92 2001 886 895
22. M.P. MacManus, K. Wong, R.J. Hicks Early mortality after radical radiotherapy for non-small-cell lung cancer: Comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center Int J Radiat Oncol Biol Phys 52 2002 351 361
23. S.M. Eschmann, G. Friedel, F. Paulsen FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy Eur J Nucl Med Mol Imaging 29 6 2002 804 808
24. 18 F] fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: A prospective study Int J Radiat Oncol Biol Phys 80 2011 1008 1014
25. E. Deniaud-Alexandre, E. Touboul, D. Lerouge Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 63 2005 1432 1441
26. E.P. Sulman, R. Komaki, A.H. Klopp Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer Radiat Oncol 4 2009 5
27. J.L. Fox, R. Rengan, W. O'Meara Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? Int J Radiat Oncol Biol Phys 62 2005 70 75
28. T. Ackerly, J. Andrews, D. Ball Display of positron emission tomography with Cadplan Australas Phys Eng Sci Med 25 2002 67 77
29. D. Lardinois, W. Weder, T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
30. W. De Wever, Y. Vankan, S. Stroobants Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Eur Respir J 29 2007 995 1002
31. M.T. Munley, L.B. Marks, C. Scarfone Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: Challenges and prospects Lung Cancer 23 1999 105 114
32. U. Nestle, K. Walter, S. Schmidt 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597
33. L.J. Vanuytsel, J.F. Vansteenkiste, S.G. Stroobants The impact of (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer Radiother Oncol 55 2000 317 324
34. 18 FDG-hybrid PET fusion Int J Radiat Oncol Biol Phys 51 4 2001 923 931
35. K. Mah, C.B. Caldwell, Y.C. Ung The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study Int J Radiat Oncol Biol Phys 52 2002 339 350
36. J. Bradley, W.L. Thorstad, S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86
37. A. van der Wel, S. Nijsten, M. Hochstenbag Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: A modeling study Int J Radiat Oncol Biol Phys 61 2005 649 655
38. D. De Ruysscher, S. Wanders, A. Minken Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study Radiother Oncol 77 2005 5 10
39. S.L. Faria, S. Menard, S. Devic Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings Int J Radiat Oncol Biol Phys 70 2008 1035 1038
40. P. Pommier, E. Touboul, S. Chabaud Impact of (18)F-FDG PET on treatment strategy and 3D radiotherapy planning in non-small cell lung cancer: A prospective multicenter study Am J Roentgenol 195 2010 350 355
41. J. Bradley, K. Bae, N. Choi A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): Primary analysis of Radiation Therapy Oncology Group (RTOG) Int J Radiat Oncol Biol Phys 82 2012 435.e1441.e1
42. M. Mac Manus, U. Nestle, K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
43. E.J. Somer, L.C. Pike, P.K. Marsden Recommendations for the use of positron emission tomography and positron emission tomography-CT for radiotherapy planning in research projects Br J Radiol 2012 Feb 28 [Epub ahead of print]
44. S. Everitt, A. Herschtal, J. Callahan High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer Cancer 116 2010 5030 5037
45. A. Grgic, U. Nestle, A. Schaefer-Schuler FDG-PET-based radiotherapy planning in lung cancer: Optimum breathing protocol and patient positioning - An intraindividual comparison Int J Radiat Oncol Biol Phys 73 2009 103 111
46. J. Van de Steene, N. Linthout, J. de Mey Definition of gross tumor volume in lung cancer: Inter-observer variability Radiother Oncol 62 2002 37 49
47. P. Bowden, R. Fisher, M. Mac Manus Measurement of lung tumor volumes using three-dimensional computer planning software Int J Radiat Oncol Biol Phys 53 2002 566 573
48. M. Bayne, R.J. Hicks, S. Everitt Reproducibility of " intelligent" contouring of gross tumor volume in non-small-cell lung cancer on PET/CT images using a standardized visual method Int J Radiat Oncol Biol Phys 77 2010 1151 1157
49. U. Nestle, A. Schaefer-Schuler, S. Kremp Target volume definition for (18)F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 2007 453 462
50. U. Nestle, S. Kremp, A. Schaefer-Schuler Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer J Nucl Med 46 2005 1342 1348
51. R. Hong, J. Halama, D. Bova Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning Int J Radiat Oncol Biol Phys 67 2007 720 726
52. K.J. Biehl, F.M. Kong, F. Dehdashti 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: Is a single standardized uptake value threshold approach appropriate? J Nucl Med 47 2006 1808 1812
53. S.A. Nehmeh, H. El-Zeftawy, C. Greco An iterative technique to segment PET lesions using a Monte Carlo based mathematical model Med Phys 36 2009 4803 4809
54. B. Yaremko, T. Riauka, D. Robinson Thresholding in PET images of static and moving targets Phys Med Biol 50 2005 5969 5982
55. V. Grégoire, T.R. Mackie State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy (ICRU report No. 83) Cancer Radiother 15 2011 555 559
56. M. Aristophanous, R.I. Berbeco, J.H. Killoran Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning Int J Radiat Oncol Biol Phys 82 2012 e99 e105
57. A. van Baardwijk, G. Bosmans, L. Boersma PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes Int J Radiat Oncol Biol Phys 68 2007 771 778
58. M. Dahele, D. Hwang, C. Peressotti Developing a methodology for three-dimensional correlation of PET-CT images and whole-mount histopathology in non-small-cell lung cancer Curr Oncol 15 2008 62 69
59. M.P. Mac Manus, R.J. Hicks, J.P. Matthews Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292
60. H.J. Aerts, A.A. van Baardwijk, S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
61. F.M. Kong, K.A. Frey, L.E. Quint A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer J Clin Oncol 25 2007 3116 3123
62. C. Gillham, D. Zips, F. Pönisch Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning? Radiother Oncol 88 2008 335 341
63. H. Vesselle, J. Grierson, L.M. Peterson 18F-fluorothymidine radiation dosimetry in human PET imaging studies J Nucl Med 44 2003 1482 1488
64. S. Everitt, R.J. Hicks, D. Ball Imaging cellular proliferation during chemo-radiotherapy: A pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 75 2009 1098 1104
65. E.E. Deschner, L.H. Gray Influence of oxygen tension on x-ray-induced chromosomal damage in Ehrlich ascites tumor cells irradiated in vitro and in vivo Radiat Res 11 1959 115 146